This is the case for LRP4 mutations that are responsible for three different pathological phenotypes in humans: CLS (MIM 212780), sclerosteosis 2 (MIM 614305) with or without syndactylies (MIM 185900) and CMS (MIM 616304)1–5. The gene discussed is LRP4; the disease is sclerosteosis 2.